286 related articles for article (PubMed ID: 21084384)
1. Interaction of glibenclamide and metformin at the level of translation in pancreatic β cells.
Wang Q; Cai Y; Van de Casteele M; Pipeleers D; Ling Z
J Endocrinol; 2011 Feb; 208(2):161-9. PubMed ID: 21084384
[TBL] [Abstract][Full Text] [Related]
2. Glibenclamide activates translation in rat pancreatic beta cells through calcium-dependent mTOR, PKA and MEK signalling pathways.
Wang Q; Heimberg H; Pipeleers D; Ling Z
Diabetologia; 2008 Jul; 51(7):1202-12. PubMed ID: 18493739
[TBL] [Abstract][Full Text] [Related]
3. A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy.
Lee MJ; Feliers D; Mariappan MM; Sataranatarajan K; Mahimainathan L; Musi N; Foretz M; Viollet B; Weinberg JM; Choudhury GG; Kasinath BS
Am J Physiol Renal Physiol; 2007 Feb; 292(2):F617-27. PubMed ID: 17018841
[TBL] [Abstract][Full Text] [Related]
4. Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells.
Dowling RJ; Zakikhani M; Fantus IG; Pollak M; Sonenberg N
Cancer Res; 2007 Nov; 67(22):10804-12. PubMed ID: 18006825
[TBL] [Abstract][Full Text] [Related]
5. Akt activation protects pancreatic beta cells from AMPK-mediated death through stimulation of mTOR.
Cai Y; Wang Q; Ling Z; Pipeleers D; McDermott P; Pende M; Heimberg H; Van de Casteele M
Biochem Pharmacol; 2008 May; 75(10):1981-93. PubMed ID: 18377870
[TBL] [Abstract][Full Text] [Related]
6. The human glucagon-like peptide-1 analogue liraglutide regulates pancreatic beta-cell proliferation and apoptosis via an AMPK/mTOR/P70S6K signaling pathway.
Miao XY; Gu ZY; Liu P; Hu Y; Li L; Gong YP; Shu H; Liu Y; Li CL
Peptides; 2013 Jan; 39():71-9. PubMed ID: 23116613
[TBL] [Abstract][Full Text] [Related]
7. Arginine-induced stimulation of protein synthesis and survival in IPEC-J2 cells is mediated by mTOR but not nitric oxide.
Bauchart-Thevret C; Cui L; Wu G; Burrin DG
Am J Physiol Endocrinol Metab; 2010 Dec; 299(6):E899-909. PubMed ID: 20841502
[TBL] [Abstract][Full Text] [Related]
8. Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth.
Rocha GZ; Dias MM; Ropelle ER; Osório-Costa F; Rossato FA; Vercesi AE; Saad MJ; Carvalheira JB
Clin Cancer Res; 2011 Jun; 17(12):3993-4005. PubMed ID: 21543517
[TBL] [Abstract][Full Text] [Related]
9. Activation of mammalian target of rapamycin signaling in spatial learning.
Qi S; Mizuno M; Yonezawa K; Nawa H; Takei N
Neurosci Res; 2010 Oct; 68(2):88-93. PubMed ID: 20599569
[TBL] [Abstract][Full Text] [Related]
10. Glibenclamide treatment recruits beta-cell subpopulation into elevated and sustained basal insulin synthetic activity.
Ling Z; Wang Q; Stangé G; In't Veld P; Pipeleers D
Diabetes; 2006 Jan; 55(1):78-85. PubMed ID: 16380479
[TBL] [Abstract][Full Text] [Related]
11. Metformin decreases IGF1-induced cell proliferation and protein synthesis through AMP-activated protein kinase in cultured bovine granulosa cells.
Tosca L; Ramé C; Chabrolle C; Tesseraud S; Dupont J
Reproduction; 2010 Feb; 139(2):409-18. PubMed ID: 19906888
[TBL] [Abstract][Full Text] [Related]
12. Intracerebroventricular administration of ouabain, a Na/K-ATPase inhibitor, activates mTOR signal pathways and protein translation in the rat frontal cortex.
Kim SH; Yu HS; Park HG; Ha K; Kim YS; Shin SY; Ahn YM
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():73-82. PubMed ID: 23643758
[TBL] [Abstract][Full Text] [Related]
13. Metformin-induced stimulation of AMP-activated protein kinase in beta-cells impairs their glucose responsiveness and can lead to apoptosis.
Kefas BA; Cai Y; Kerckhofs K; Ling Z; Martens G; Heimberg H; Pipeleers D; Van de Casteele M
Biochem Pharmacol; 2004 Aug; 68(3):409-16. PubMed ID: 15242807
[TBL] [Abstract][Full Text] [Related]
14. Raptor-rictor axis in TGFbeta-induced protein synthesis.
Das F; Ghosh-Choudhury N; Mahimainathan L; Venkatesan B; Feliers D; Riley DJ; Kasinath BS; Choudhury GG
Cell Signal; 2008 Feb; 20(2):409-23. PubMed ID: 18068336
[TBL] [Abstract][Full Text] [Related]
15. IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways.
Bibollet-Bahena O; Almazan G
J Neurochem; 2009 Jun; 109(5):1440-51. PubMed ID: 19453943
[TBL] [Abstract][Full Text] [Related]
16. Time course changes in signaling pathways and protein synthesis in C2C12 myotubes following AMPK activation by AICAR.
Williamson DL; Bolster DR; Kimball SR; Jefferson LS
Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E80-9. PubMed ID: 16760336
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferation of cardamonin is involved in mTOR on aortic smooth muscle cells in high fructose-induced insulin resistance rats.
Liao Q; Shi DH; Zheng W; Xu XJ; Yu YH
Eur J Pharmacol; 2010 Sep; 641(2-3):179-86. PubMed ID: 20566415
[TBL] [Abstract][Full Text] [Related]
18. Leucine stimulates mammalian target of rapamycin signaling in C2C12 myoblasts in part through inhibition of adenosine monophosphate-activated protein kinase.
Du M; Shen QW; Zhu MJ; Ford SP
J Anim Sci; 2007 Apr; 85(4):919-27. PubMed ID: 17178807
[TBL] [Abstract][Full Text] [Related]
19. Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase.
Hosono K; Endo H; Takahashi H; Sugiyama M; Uchiyama T; Suzuki K; Nozaki Y; Yoneda K; Fujita K; Yoneda M; Inamori M; Tomatsu A; Chihara T; Shimpo K; Nakagama H; Nakajima A
Mol Carcinog; 2010 Jul; 49(7):662-71. PubMed ID: 20564343
[TBL] [Abstract][Full Text] [Related]
20. Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability.
Beugnet A; Tee AR; Taylor PM; Proud CG
Biochem J; 2003 Jun; 372(Pt 2):555-66. PubMed ID: 12611592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
